BBI-4000: Any idea of what this might be?

Amherst

Well-known member
I stumbled across this link today with the following description:

"BBI-4000, a novel topical soft anticholingeric, is being developed for the treatment of hyperhidrosis, with initial human clinical studies planned to commence during 2014."

Here's the full link, which has little info, presumably as Brickell does not want to give away its secrets:

Brickell Biotech, Inc. | Pipeline

Any idea of what a "novel topical soft anticholingeric" might be? Is it something like glycopyrrolate solution? I'm delighted to see, though, that some commercial start-ups are starting to sense the financial potential in coming up with new treatments for hyperhidrosis.
 

Sprawling

Well-known member
We probably will not hear anything about for several years since the beginning trial stages starts in 2014.
 

HHDisturbed

Well-known member
Sounds like another possible treatment in development but a ways off before availability. Still, it is not a cure and there are only treatments. Hopefully those treatments just continue to improve and still be affordable for most people.
 
Top